Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$900M |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$866M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$596M |
| 4 |
Clarivate
CLVT
|
+$284M |
| 5 |
Mastercard
MA
|
+$272M |
Top Sells
| 1 |
Wolfspeed
WOLF
|
+$1.11B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1,000M |
| 3 |
Apple
AAPL
|
+$925M |
| 4 |
Intel
INTC
|
+$462M |
| 5 |
Microsoft
MSFT
|
+$435M |
Sector Composition
| 1 | Technology | 25.57% |
| 2 | Financials | 13.1% |
| 3 | Healthcare | 12.32% |
| 4 | Consumer Discretionary | 12.3% |
| 5 | Communication Services | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Interface
TILE
$1.65B
| $4.93M | ﹤0.01% |
340,864
-66,398
| -16% | -$960K |
|
2202
S&T Bancorp
STBA
$1.49B
| $4.92M | ﹤0.01% |
166,941
-11,296
| -6% | -$333K |
|
|
MORF
2203
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $4.92M | ﹤0.01% |
72,820
-47,472
| -39% | -$3.2M |
|
2204
Standex International
SXI
$2.46B
| $4.89M | ﹤0.01% |
50,094
-1,719
| -3% | -$168K |
|
|
NVEE
2205
DELISTED
NV5 Global
NVEE
| $4.88M | ﹤0.01% |
191,296
-5,744
| -3% | -$147K |
|
2206
Arbutus Biopharma
ABUS
$870M
| $4.87M | ﹤0.01% |
1,119,611
+893,599
| +395% | +$3.89M |
|
|
NTST
2207
NETSTREIT Corp
NTST
$1.74B
| $4.87M | ﹤0.01% |
199,305
-31,725
| -14% | -$775K |
|
|
CHS
2208
DELISTED
Chicos FAS, Inc.
CHS
| $4.86M | ﹤0.01% |
1,031,539
+79,678
| +8% | +$375K |
|
2209
Century Aluminum
CENX
$2.32B
| $4.85M | ﹤0.01% |
372,026
-15,214
| -4% | -$198K |
|
2210
InMode
INMD
$957M
| $4.84M | ﹤0.01% |
+60,644
| New | +$4.84M |
|
2211
ORIX
IX
$30B
| $4.83M | ﹤0.01% |
255,600
-35
| -0% | -$662 |
|
2212
Mustang Bio
MBIO
$11.6M
| $4.83M | ﹤0.01% |
2,237
-162
| -7% | -$350K |
|
2213
Universal Corp
UVV
$1.38B
| $4.83M | ﹤0.01% |
100,683
-4,134
| -4% | -$198K |
|
2214
First Foundation Inc
FFWM
$489M
| $4.82M | ﹤0.01% |
193,758
-5,504
| -3% | -$137K |
|
2215
ALX Oncology
ALXO
$58.9M
| $4.81M | ﹤0.01% |
65,185
-29,752
| -31% | -$2.2M |
|
|
IMGN
2216
DELISTED
Immunogen Inc
IMGN
| $4.81M | ﹤0.01% |
830,023
-64,892
| -7% | -$376K |
|
2217
Autohome
ATHM
$3.45B
| $4.79M | ﹤0.01% |
102,023
+33,000
| +48% | +$1.55M |
|
2218
US Physical Therapy
USPH
$1.24B
| $4.79M | ﹤0.01% |
43,290
-16,674
| -28% | -$1.84M |
|
2219
Alamo Group
ALG
$2.49B
| $4.78M | ﹤0.01% |
32,883
-2,547
| -7% | -$370K |
|
2220
Interparfums
IPAR
$3.46B
| $4.77M | ﹤0.01% |
68,514
-2,324
| -3% | -$162K |
|
|
DCPH
2221
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $4.77M | ﹤0.01% |
144,679
-7,278
| -5% | -$240K |
|
|
CSII
2222
DELISTED
Cardiovascular Systems, Inc.
CSII
| $4.77M | ﹤0.01% |
130,380
-5,750
| -4% | -$210K |
|
2223
Enanta Pharmaceuticals
ENTA
$185M
| $4.76M | ﹤0.01% |
81,546
+390
| +0.5% | +$22.8K |
|
|
VRAY
2224
DELISTED
ViewRay, Inc.
VRAY
| $4.76M | ﹤0.01% |
727,819
-1,050,453
| -59% | -$6.87M |
|
2225
Hanmi Financial
HAFC
$748M
| $4.75M | ﹤0.01% |
252,678
+30,874
| +14% | +$580K |
|